Extended interval dosing with ocrelizumab in multiple sclerosis.
Novak F, Bajwa HM, Østergaard K, Berg JM, Madsen JS, Olsen DA, Urbonaviciute I, Illes Z, Stilund ML, Romme Christensen J, Bramow S, Sellebjerg F, Sejbaek T.
Novak F, et al. Among authors: olsen da.
Mult Scler. 2024 Jun;30(7):847-856. doi: 10.1177/13524585241245296. Epub 2024 Apr 22.
Mult Scler. 2024.
PMID: 38646949